Autism Impact Fund
VC · San Francisco · United States
Stages
Investment region
Industries
Profile
Autism Impact Fund (AIF) is a healthcare technology and innovation firm based in San Francisco, California, founded in 2020. The firm focuses on investing in solutions for behavioral health, mental health, autism, and complex chronic conditions. AIF is led by a team with deep expertise in healthcare and technology, aiming to transform the treatment landscape for these conditions. AIF primarily invests in the life sciences and digital health sectors, targeting early-stage to later-stage ventures. The firm is known for its impact investment approach, with a focus on health-related innovations. AIF manages multiple funds, including the Autism Impact Fund II, which has an AUM of $10 million and was launched in 2025. Notable investments by AIF include BioROSA Technologies - diagnostic equipment, Floreo - educational software, SpectrumAi - enterprise systems for healthcare, and Cortica - clinics and outpatient services. These investments highlight AIF's commitment to advancing healthcare solutions for neurodevelopmental disorders.
Contatti (2)
| Nome | Title | Telefono | ||
|---|---|---|---|---|
| Co-Founder & Managing Partner | — | — | — | |
| Chief Investment Officer | — | — | — |
Name, email and phone are partially hidden. Subscribe to see them in full.